{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:30:01Z","timestamp":1773009001291,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,21]]},"DOI":"10.7759\/cureus.50927","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T07:03:30Z","timestamp":1703228610000},"source":"Crossref","is-referenced-by-count":1,"title":["Hyperprolactinemia in Functional Dyspepsia: The Entangled Domperidone Link"],"prefix":"10.7759","author":[{"given":"Devansh","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Akram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1501505","article-title":"Functional dyspepsia","volume":"373","author":"Talley NJ","year":"2015","unstructured":"Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med. 2015, 373:1853-63. 10.1056\/NEJMra1501505","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-9_part_2-200105011-00004","article-title":"Dyspepsia","volume":"134","author":"Bytzer P","year":"2001","unstructured":"Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med. 2001, 134:815-22. 10.7326\/0003-4819-134-9_part_2-200105011-00004","journal-title":"Ann Intern Med"},{"key":"ref3","article-title":"Functional disorders of the stomach","volume":"7","author":"Koch KL","year":"1996","unstructured":"Koch KL, Stern RM. Functional disorders of the stomach. Semin Gastrointest Dis. 1996, 7:185-95.","journal-title":"Semin Gastrointest Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8553(05)70367-8","article-title":"Functional dyspepsia. Insights on mechanisms and management strategies","volume":"25","author":"Malagelada JR","year":"1996","unstructured":"Malagelada JR. Functional dyspepsia. Insights on mechanisms and management strategies. Gastroenterol Clin North Am. 1996, 25:103-12. 10.1016\/s0889-8553(05)70367-8","journal-title":"Gastroenterol Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.70.821.154","article-title":"Prevalence of dyspepsia: the epidemiology of overlapping symptoms","volume":"70","author":"Grainger SL","year":"1994","unstructured":"Grainger SL, Klass HJ, Rake MO, Williams JG. Prevalence of dyspepsia: the epidemiology of overlapping symptoms. Postgrad Med J. 1994, 70:154-61. 10.1136\/pgmj.70.821.154","journal-title":"Postgrad Med J"},{"key":"ref6","article-title":"Epidemiology of dyspepsia in the general population in Mumbai","volume":"20","author":"Shah SS","year":"2001","unstructured":"Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol. 2001, 20:103-6.","journal-title":"Indian J Gastroenterol"},{"key":"ref7","article-title":"Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force","volume":"27","author":"Ghoshal UC","year":"2008","unstructured":"Ghoshal UC, Abraham P, Bhatt C, et al.. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008, 27:22-8.","journal-title":"Indian J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.499","article-title":"Pathophysiological abnormalities in functional dyspepsia subgroups according to the Rome III Criteria","volume":"112","author":"Vanheel H","year":"2017","unstructured":"Vanheel H, Carbone F, Valvekens L, et al.. Pathophysiological abnormalities in functional dyspepsia subgroups according to the Rome III Criteria. Am J Gastroenterol. 2017, 112:132-40. 10.1038\/ajg.2016.499","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(98)70012-5","article-title":"Role of impaired gastric accommodation to a meal in functional dyspepsia","volume":"115","author":"Tack J","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998, 115:1346-52. 10.1016\/s0016-5085(98)70012-5","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01142.x","article-title":"Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men","volume":"102","author":"Pilichiewicz AN","year":"2007","unstructured":"Pilichiewicz AN, Horowitz M, Russo A, et al.. Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol. 2007, 102:1276-83. 10.1111\/j.1572-0241.2007.01142.x","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.10.019","article-title":"Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia","volume":"130","author":"Karamanolis G","year":"2006","unstructured":"Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology. 2006, 130:296-303. 10.1053\/j.gastro.2005.10.019","journal-title":"Gastroenterology"},{"key":"ref12","article-title":"Nonulcer dyspepsia","volume":"4","author":"Scolapio JS","year":"1996","unstructured":"Scolapio JS, Camilleri M. Nonulcer dyspepsia. Gastroenterologist. 1996, 4:13-23.","journal-title":"Gastroenterologist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1023\/a:1018803129779","article-title":"Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis","volume":"43","author":"Quartero AO","year":"1998","unstructured":"Quartero AO, de Wit NJ, Lodder AC, Numans ME, Smout AJ, Hoes AW. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci. 1998, 43:2028-33. 10.1023\/a:1018803129779","journal-title":"Dig Dis Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.006","article-title":"Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia","volume":"127","author":"Delgado-Aros S","year":"2004","unstructured":"Delgado-Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology. 2004, 127:1685-94. 10.1053\/j.gastro.2004.09.006","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00391.x","article-title":"Detailed characterization of epidemiology of uninvestigated dyspepsia and its impact on quality of life among African Americans as compared to Caucasians","volume":"101","author":"Minocha A","year":"2006","unstructured":"Minocha A, Wigington WC, Johnson WD. Detailed characterization of epidemiology of uninvestigated dyspepsia and its impact on quality of life among African Americans as compared to Caucasians. Am J Gastroenterol. 2006, 101:336-42. 10.1111\/j.1572-0241.2006.00391.x","journal-title":"Am J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-014-1022-3","article-title":"Evidence-based clinical practice guidelines for functional dyspepsia","volume":"50","author":"Miwa H","year":"2015","unstructured":"Miwa H, Kusano M, Arisawa T, et al.. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol. 2015, 50:125-39. 10.1007\/s00535-014-1022-3","journal-title":"J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-03014-9","article-title":"Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis","volume":"23","author":"Qi Q","year":"2023","unstructured":"Qi Q, Wang N, Liu H, Li Y. Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis. BMC Gastroenterol. 2023, 23:370. 10.1186\/s12876-023-03014-9","journal-title":"BMC Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01255.x","article-title":"Domperidone: review of pharmacology and clinical applications in gastroenterology","volume":"102","author":"Reddymasu SC","year":"2007","unstructured":"Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007, 102:2036-45. 10.1111\/j.1572-0241.2007.01255.x","journal-title":"Am J Gastroenterol"},{"key":"ref19","article-title":"Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry","volume":"55 Suppl 1","author":"Weihrauch TR","year":"1979","unstructured":"Weihrauch TR, F\u00f6rster CF, Krieglstein J. Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry. Postgrad Med J. 1979, 55 Suppl 1:7-10.","journal-title":"Postgrad Med J"},{"key":"ref20","article-title":"The GI drug column. Subcommittee on FDA related matters, American College of Gastroenterology","volume":"78","author":"Friedman G","year":"1983","unstructured":"Friedman G. The GI drug column. Subcommittee on FDA related matters, American College of Gastroenterology. Am J Gastroenterol. 1983, 78:47-8.","journal-title":"Am J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-7-2-169","article-title":"Structural features of prolactins and growth hormones that can be related to their biological properties","volume":"7","author":"Nicoll CS","year":"1986","unstructured":"Nicoll CS, Mayer GL, Russell SM. Structural features of prolactins and growth hormones that can be related to their biological properties. Endocr Rev. 1986, 7:169-203. 10.1210\/edrv-7-2-169","journal-title":"Endocr Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.19.3.0334","article-title":"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice","volume":"19","author":"Bole-Feysot C","year":"1998","unstructured":"Bole-Feysot C, Goffin V, Edery M. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. EndocrRev. 1998, 19:225-68. 10.1210\/edrv.19.3.0334","journal-title":"EndocrRev"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.4103\/0253-7613.111913","article-title":"Domperidone induced galactorrhea: an unusual presentation of a common drug","volume":"45","author":"Poovathingal M","year":"2013","unstructured":"Poovathingal M, Bhat R, Ramamoorthi. Domperidone induced galactorrhea: an unusual presentation of a common drug. Indian J Pharmacol. 2013, 45:307-8.","journal-title":"Indian J Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v62i2.440","article-title":"Monitoring of serum prolactin in pediatric patients with cystic fibrosis who are receiving domperidone","volume":"62","author":"Cho E","year":"2009","unstructured":"Cho E, Ho S, Gerber P, Davidson AG. Monitoring of serum prolactin in pediatric patients with cystic fibrosis who are receiving domperidone. Can J Hosp Pharm. 2009, 62:119-26. 10.4212\/cjhp.v62i2.440","journal-title":"Can J Hosp Pharm"},{"key":"ref25","article-title":"Effect of domperidone on prolactin (PRL) and thyrotrophin (TSH) secretion","volume":"254","author":"Kaufman JM","year":"1981","unstructured":"Kaufman JM, Elewaut A, Vermeulen A. Effect of domperidone on prolactin (PRL) and thyrotrophin (TSH) secretion. Arch Int Pharmacodyn Ther. 1981, 254:293-303.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"ref26","article-title":"Comparison of efficacy and safety of Levosulpiride and Domperidone in functional dyspepsia","volume":"2","author":"Jain C","year":"2015","unstructured":"Jain C, Kumar M, Advani U, Sharma N, Bhargava J, Sharma K. Comparison of efficacy and safety of Levosulpiride and Domperidone in functional dyspepsia. IRJPBS. 2015, 2:20-30.","journal-title":"IRJPBS"},{"key":"ref27","article-title":"Efficacy of acotiamide in PDS type functional dyspepsia symptoms with and without PPI and laxative co-therapy","volume":"71","author":"Narayanan V","year":"2018","unstructured":"Narayanan V, Pallewar S, Bhargava A. Efficacy of acotiamide in PDS type functional dyspepsia symptoms with and without PPI and laxative co-therapy. Indian Pract. 2018, 71:6.","journal-title":"Indian Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.4.401","article-title":"Dyspepsia in England and Scotland","volume":"31","author":"Jones RH","year":"1990","unstructured":"Jones RH, Lydeard SE, Hobbs FD, et al.. Dyspepsia in England and Scotland. Gut. 1990, 31:401-5. 10.1136\/gut.31.4.401","journal-title":"Gut"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.057","article-title":"Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study","volume":"138","author":"Zagari RM","year":"2010","unstructured":"Zagari RM, Law GR, Fuccio L, Cennamo V, Gilthorpe MS, Forman D, Bazzoli F. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology. 2010, 138:1302-11. 10.1053\/j.gastro.2009.12.057","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000332404","article-title":"A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration","volume":"84","author":"Matsueda K","year":"2011","unstructured":"Matsueda K, Hongo M, Ushijima S, Akiho H. A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration. Digestion. 2011, 84:261-8. 10.1159\/000332404","journal-title":"Digestion"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.27.521","article-title":"Effects of domperidone on serum prolactin levels in human beings","volume":"27","author":"Fujino T","year":"1980","unstructured":"Fujino T, Kato H, Yamashita S, et al.. Effects of domperidone on serum prolactin levels in human beings. Endocrinol Jpn. 1980, 27:521-5. 10.1507\/endocrj1954.27.521","journal-title":"Endocrinol Jpn"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.56.P885","article-title":"Very high prolactin levels associated to domperidone therapy","volume":"56","author":"Vilar L","year":"2018","unstructured":"Vilar L, Vilar C. Very high prolactin levels associated to domperidone therapy. Endocrine Abstracts. 2018, 56:P885. 10.1530\/endoabs.56.P885","journal-title":"Endocrine Abstracts"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211291-hyperprolactinemia-in-functional-dyspepsia-the-entangled-domperidone-link","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:21Z","timestamp":1707509421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211291-hyperprolactinemia-in-functional-dyspepsia-the-entangled-domperidone-link"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.50927","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,21]]}}}